Insights to clinical use of serial determination in titers of cyclic citrullinated peptide autoantibodies

Mediators of Inflammation

Volumn 2007, Issue , 2007, Pages

  Kogure, Toshiaki ^a   Tatsumi, Takeshi ^a   Fujinaga, Hiroshi ^b   Niizawa, Atsushi ^c   Terasawa, Katsutoshi ^d  

^a GUNMA UNIVERSITY   (Japan)

^b TOYAMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^c Kanebo Memorial Hospital   (Japan)

^d CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BUCILLAMINE; CYCLIC CITRULLINATED ANTIBODY; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE; TACROLIMUS; UNCLASSIFIED DRUG; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; LARSEN SCORE; PRIORITY JOURNAL; PROGNOSIS; RHEUMATOID ARTHRITIS; X RAY FILM; BLOOD; IMMUNOLOGY; MALE; MIDDLE AGED;

ADULT; AGED; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC;

EID: 35348908051     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2007/12367     Document Type: Article

References (8)

1. O. Shovman B. Gilburd G. Zandman-Goddard The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis. Clinical and Developmental Immunology 12 3 2005 197 202
2. K. Raza k.raza@bham.ac.uk M. Breese P. Nightingale Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis. Journal of Rheumatology 32 2 2005 231 238
3. E. Lindqvist elisabet.lindqvist@reum.lu.se K. Eberhardt K. Bendtzen D. Heinegȧrd T. Saxne Prognostic laboratory markers of joint damage in rheumatoid arthritis. Annals of the Rheumatic Diseases 64 2 2005 196 201
4. O. Meyer P. Nicaise-Roland M. dos Santos Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis. Arthritis Research & Therapy 8 2 2006 R40
5. A. Larsen K. Dale M. Eek Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiologica Diagnosis 18 4 1977 481 491
6. E. Lindqvist elisabet.lindqvist@reum.lu.se K. Jonsson T. Saxne K. Eberhardt Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis. Annals of the Rheumatic Diseases 62 7 2003 611 616
7. L. De Rycke leen.derycke@Ugent.be X. Verhelst E. Kruithof Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis. Annals of the Rheumatic Diseases 64 2 2005 299 302
8. P. Caramaschi paola.caramaschi@azosp.vr.it D. Biasi E. Tonolli Antibodies against cyclic citrullinated peptides in patients affected by rheumatoid arthritis before and after infliximab treatment. Rheumatology International 26 1 2005 58 62